Review



fate1 targeted shrnas  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 91
      Buy from Supplier

    Structured Review

    Addgene inc fate1 targeted shrnas
    Fig. 1: <t>FATE1</t> is a Target of the Oncogenic Transcription Factor EWSR1-FLI1. (A) FATE1 607
    Fate1 Targeted Shrnas, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fate1+targeted+shrnas/10__1128_slash_mcb__00138___19-175-12-56?v=Addgene+inc
    Average 91 stars, based on 4 article reviews
    fate1 targeted shrnas - by Bioz Stars, 2026-07
    91/100 stars

    Images

    1) Product Images from "EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival"

    Article Title: EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival

    Journal: Molecular and Cellular Biology

    doi: 10.1128/mcb.00138-19

    Fig. 1: FATE1 is a Target of the Oncogenic Transcription Factor EWSR1-FLI1. (A) FATE1 607
    Figure Legend Snippet: Fig. 1: FATE1 is a Target of the Oncogenic Transcription Factor EWSR1-FLI1. (A) FATE1 607

    Techniques Used:

    Fig. 5: FATE1 Destabilizes BNIP3L. (A, B) 72 hours after siRNA transfection, WCLs were collected 655
    Figure Legend Snippet: Fig. 5: FATE1 Destabilizes BNIP3L. (A, B) 72 hours after siRNA transfection, WCLs were collected 655

    Techniques Used: Transfection



    Similar Products

    fate1 targeted shrnas  (Addgene inc)
    91
    Addgene inc fate1 targeted shrnas
    Fig. 1: <t>FATE1</t> is a Target of the Oncogenic Transcription Factor EWSR1-FLI1. (A) FATE1 607
    Fate1 Targeted Shrnas, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fate1+targeted+shrnas/10__1128_slash_mcb__00138___19-175-12-56?v=Addgene+inc
    Average 91 stars, based on 1 article reviews
    fate1 targeted shrnas - by Bioz Stars, 2026-07
    91/100 stars
    		  Buy from Supplier

    Image Search Results


    Fig. 1: FATE1 is a Target of the Oncogenic Transcription Factor EWSR1-FLI1. (A) FATE1 607

    Journal: Molecular and Cellular Biology

    Article Title: EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival

    doi: 10.1128/mcb.00138-19

    Figure Lengend Snippet: Fig. 1: FATE1 is a Target of the Oncogenic Transcription Factor EWSR1-FLI1. (A) FATE1 607

    Article Snippet: For shRNA experiments pLKO.1 vectors from The RNA 312 Consortium (TRC) expressing FATE1 targeted shRNAs (A7: TRCN0000130192 and A9: 313 on M ay 4, 2019 by guest http://m cb.asm .org/ D ow nloaded from 12 TRCN0000146597) were obtained from the UNC Lentiviral core and a non-targeting shRNA in pLKO.1 314 (shSCR) was used as a control (Addgene).

    Techniques:

    Fig. 5: FATE1 Destabilizes BNIP3L. (A, B) 72 hours after siRNA transfection, WCLs were collected 655

    Journal: Molecular and Cellular Biology

    Article Title: EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival

    doi: 10.1128/mcb.00138-19

    Figure Lengend Snippet: Fig. 5: FATE1 Destabilizes BNIP3L. (A, B) 72 hours after siRNA transfection, WCLs were collected 655

    Article Snippet: For shRNA experiments pLKO.1 vectors from The RNA 312 Consortium (TRC) expressing FATE1 targeted shRNAs (A7: TRCN0000130192 and A9: 313 on M ay 4, 2019 by guest http://m cb.asm .org/ D ow nloaded from 12 TRCN0000146597) were obtained from the UNC Lentiviral core and a non-targeting shRNA in pLKO.1 314 (shSCR) was used as a control (Addgene).

    Techniques: Transfection